Generated by DeepSeek V3.2| deferred prosecution agreement | |
|---|---|
| Name | Deferred Prosecution Agreement |
| Synonyms | DPA |
| Related terms | Non-prosecution agreement, Plea bargain |
| Jurisdiction | United States, United Kingdom, Canada, France |
deferred prosecution agreement. A deferred prosecution agreement is a voluntary alternative to criminal prosecution reached between a prosecutor and an organization, typically a corporation, to resolve alleged violations of law. Under its terms, the government agrees to suspend or "defer" filing criminal charges in exchange for the organization meeting specific conditions, such as paying fines, cooperating with ongoing investigations, and implementing robust compliance program reforms. If the organization successfully fulfills all agreement terms by the end of a set period, often several years, the government dismisses the charges. This mechanism aims to balance law enforcement objectives with the desire to avoid the severe collateral consequences, such as destabilizing a major employer or harming innocent shareholders, that could result from a full criminal conviction.
A deferred prosecution agreement functions as a form of pre-trial diversion, primarily utilized in cases involving complex white-collar crime, foreign corrupt practices, and financial fraud. Its core purpose is to hold organizations accountable for misconduct while incentivizing and mandating corporate behavioral reform. Prosecutors from bodies like the U.S. Department of Justice or the Serious Fraud Office in the United Kingdom employ these agreements to secure substantial financial penalties, victim restitution, and ongoing cooperation without triggering the potentially catastrophic outcomes of a criminal indictment, such as the loss of necessary business licenses or collapse of a public company. The overarching goal is to promote corporate citizenship, protect the public and financial markets, and conserve judicial resources that would otherwise be expended in lengthy trials against large entities like HSBC or GlaxoSmithKline.
The legal authority for deferred prosecution agreements stems from the prosecutorial discretion inherent in agencies like the U.S. Department of Justice, with formal guidance outlined in documents such as the Justice Manual's Principles of Federal Prosecution of Business Organizations. In the United Kingdom, the power is codified under the Crime and Courts Act 2013. Common mandatory requirements within an agreement include payment of a significant monetary penalty, often calculated via guidelines from the U.S. Sentencing Commission, full admission of stipulated facts, and complete cooperation with any investigation into individuals, which may involve waiving attorney–client privilege. Organizations are typically required to hire an independent corporate monitor, approved by the government, such as a former FBI director or a major law firm, to oversee and report on the implementation of enhanced internal controls and ethics training programs. Failure to comply with any term can result in the government revoking the agreement and proceeding with the original criminal charges.
High-profile deferred prosecution agreements have involved some of the world's largest corporations and financial institutions. In 2012, HSBC Holdings entered into a landmark agreement with the U.S. Department of Justice to resolve charges related to money laundering for Mexican drug cartels, paying a record $1.9 billion fine and agreeing to a five-year monitoring period. Similarly, in 2016, Deutsche Bank reached a $7.2 billion agreement with the U.S. Department of Justice over its sale of toxic mortgage-backed securities in the lead-up to the 2008 financial crisis. Outside finance, Rolls-Royce Holdings entered into a combined agreement with authorities in the United Kingdom, the United States, and Brazil in 2017 to settle longstanding allegations of bribery and corruption, resulting in payments exceeding £670 million. More recently, in 2020, Goldman Sachs subsidiaries agreed to a deferred prosecution agreement to resolve charges stemming from the 1MDB scandal, implicating figures like Jho Low and former officials in Malaysia.
Critics, including members of the U.S. Senate and legal scholars, argue that deferred prosecution agreements allow powerful corporations to effectively purchase immunity from criminal convictions, creating a "too big to jail" doctrine. A major controversy is the perceived lack of individual accountability, as agreements often shield corporate executives from prosecution while the entity itself pays a fine, a practice scrutinized after the 2008 financial crisis. The selection and cost of independent monitors have also drawn criticism, with concerns about potential conflicts of interest and the creation of a lucrative industry for former U.S. Department of Justice officials. Furthermore, some argue these agreements are used punitively by administrations, such as during the Obama administration or the Trump administration, to impose sweeping operational changes on companies that extend beyond the original misconduct, effectively outsourcing corporate governance to the state.
Deferred prosecution agreements differ significantly from other common legal resolutions. Unlike a plea bargain, which results in a formal criminal conviction upon a guilty plea, a deferred prosecution agreement avoids a conviction if terms are met. A non-prosecution agreement is a less formal cousin, often used for less severe misconduct, where charges are never filed publicly in exchange for compliance, as seen in some cases with the Securities and Exchange Commission. Both contrast with a corporate integrity agreement, which is a civil settlement typically used in healthcare fraud cases enforced by the U.S. Department of Health and Human Services. Compared to a full-scale trial like the one pursued against Arthur Andersen following the Enron scandal, which led to the firm's collapse, deferred prosecution agreements are designed to be a more measured tool that seeks to reform rather than destroy a corporate defendant.